Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
EXTON, Pa., March 06, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective...
-
SALT LAKE CITY, March 06, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a worldwide leader in personalized medicine, announced today that the American Association of Clinical...
-
LOS ANGELES, March 02, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink:VDRM), announced today that it is refuting the announcement by Kasten, Inc. claiming he US District Federal Court ruled...
-
AMES, Iowa, March 01, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today reported consolidated financial results for the fourth quarter and year ended 2017, as well as...
-
AUSTIN, Texas, March 01, 2018 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) and Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, today announced that a new audio...
-
SALT LAKE CITY, March 01, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, continues to demonstrate an unmatched commitment...
-
Fourth Quarter 2017 Net Sales of $218 Million; Full-Year 2017 Net Sales of $745 Million Fourth Quarter 2017 Net Income From Continuing Operations of $27 Million; Non-GAAP Adjusted EBITDA From...
-
Sellbyville, Delaware, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Polyglycolic Acid Market is poised to exceed USD 9 billion by 2024; according to a new research report by Global Market Insights,...
-
ATLANTA, Feb. 26, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – Consorteum Holdings, Inc. ("Consorteum" or the "Company") (OTCPK:CSRH), a software development company and mobile device solutions...
-
Acuitas has No Further Rights to Use or Sublicense Arbutus LNP TechnologyArbutus Consolidates LNP Patent Estate Enabling RNAi, mRNA, and Gene-editing Therapeutics VANCOUVER, B.C. and WARMINSTER, Pa.,...